The Canadian Partnership for Tomorrow's Health (CanPATH), including the BC Generations Project, helmed by Dr. Parveen Bhatti, has been awarded $1.75 million by the COVID-19 Immunity Task Force to support efforts in the assessment of COVID-19 seroprevalence across Canada. Monitoring seroprevalence is crucial to understanding infection dynamics so that public health responses can be appropriately planned. The funding will be used to collect biologic samples from 20,000 CanPATH participants, and depending on response rates, additional funding to later collect a second set of samples from the same participants will be considered.
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.